[1] 张春宁, 林华明, 麦大海,等. 肝动脉化疗栓塞术治疗中晚期原发性肝癌及预后相关因素分析. 肝脏, 2018, 23:229-231.
[2] Grisanti S, Cosentini D, Tovazzi V, et al. Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma. Support Care Cancer, 2018, 26:1-7.
[3] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 临床肝胆病杂志, 2011, 20:929-946.
[4] 陈静, 张遂亮. 肝癌患者TACE术后肝功能损害的调查研究. 实用临床医药杂志, 2017, 21:202-204.
[5] 武中林, 吴勇超, 杨超,等. 原发性肝癌经导管肝动脉化疗栓塞术后应用不同保肝方案的效果比较研究. 中国全科医学, 2017, 20:2862-2867.
[6] 肖朝辉, 刘荣. 肝癌患者术后复发分子标志物的临床研究进展. 中华肝胆外科杂志, 2017, 23:277-281.
[7] Kalimeris K, Briassoulis P, Ntzouvani A, et al. N-acetylcysteine ameliorates liver injury in a rat model of intestinal ischemia reperfusion. J Surg Res, 2016, 206:263-272.
[8] Borlak J, Van Bömmel F, Berg T. N‐acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury. Liver Int, 2018, 38:365-376.
[9] Grendar J, Ouellet J F, Mckay A, et al. Effect of N‐acetylcysteine on liver recovery after resection: A randomized clinical trial. J Surg Oncol, 2016, 114:446-450. |
